Breaking News
0

DelMar Pharmaceuticals Inc (DMPI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow DelMar Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.519 +0.070    +15.73%
15:59:34 - Closed. Currency in USD ( Disclaimer )
After Hours
0.529
+0.010
+1.850%
17:36:26 - Real-time Data
Type: Equity
Market: United States
ISIN: US2470783067 
CUSIP: 247078306
  • Volume: 1,133,762
  • Bid/Ask: 0.500 / 0.530
  • Day's Range: 0.474 - 0.568
Invest Now
| AD |
DelMar Pharma 0.519 +0.070 +15.73%
Invest Now
| AD |

DMPI Overview

 
This is the main DelMar Pharmaceuticals Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.448
Day's Range0.474 - 0.568
RevenueN/A
Open0.427
52 wk Range0.402 - 7
EPS - 3.18
Volume1,133,762
Market Cap5.07M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)810,184
P/E RatioN/A
Beta1.27
1-Year Change - 91.83%
Shares Outstanding11,388,483
Next Earnings DateNov 18, 2019
What is your sentiment on DelMar Pharma?
or
Market is currently closed. Voting is open during market hours.

DelMar Pharmaceuticals Inc News


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Neutral Strong Sell
Technical Indicators Strong Buy Strong Buy Strong Buy Neutral Strong Sell
Summary Strong Buy Strong Buy Strong Buy Neutral Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Belt Hold Bearish 30 Current
Dark Cloud Cover 30 Current
Bullish Engulfing 1W Current
Completed Patterns
Three Inside Up 30 4 Oct 17, 2019 01:30PM
Bullish Engulfing 1W 5 Sep 08, 2019
Bullish doji Star 1D 6 Oct 09, 2019

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 235.30 236.15 233.53 +0.85 +0.36% 16.79M 15:59:58  
  Facebook 190.40 190.82 188.80 +0.81 +0.43% 9.49M 15:59:58  
  Alphabet A 1,253.32 1,263.42 1,250.00 +10.11 +0.81% 1.03M 15:59:58  
  Microsoft 139.68 141.42 139.02 -0.80 -0.57% 21.19M 15:59:58  
  Netflix 293.28 308.74 288.34 +6.90 +2.41% 38.23M 15:59:58  
  Tesla 261.96 264.78 260.23 +2.21 +0.85% 4.76M 15:59:57  
  Caterpillar 132.10 132.86 130.18 +1.92 +1.47% 3.37M 15:59:58  
  Amazon.com 1,788.11 1,798.51 1,782.30 +10.68 +0.60% 2.58M 15:59:58  
  Lockheed Martin 377.02 384.10 376.32 -5.80 -1.52% 898.05K 15:59:58  
  Alibaba ADR 176.83 178.59 175.24 -0.30 -0.17% 7.49M 15:59:58  

DelMar Pharmaceuticals Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

4

Equity Type

ORD

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being evaluated in a Phase II clinical trial for the treatment of refractory GBM. In addition to its clinical development activities in the United States, the Company has obtained certain commercial rights to VAL-083 in China where it is approved as a chemotherapy for the treatment of chronic myelogenous leukemia (CML) and lung cancer. Its drug discovery research focuses on identifying validated clinical and commercial-stage compounds, and establishing a scientific rationale for development in orphan drug indications. VAL-083 is an alkylating agent, which crosses the blood-brain-barrier (BBB).

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Securities Investor Protection Corporation (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DMPI Comments

Write your thoughts about DelMar Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Roberto Tacconelli
RobertoT 12 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any news today or just spiking?
Yolo Buffet
Yolo Buffet Oct 17, 2018 12:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hey man
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email